Journal: eLife
Article Title: UBE2G1 governs the destruction of cereblon neomorphic substrates
doi: 10.7554/eLife.40958
Figure Lengend Snippet: ( A– D ) In vitro ubiquitination of IKZF1 ( A and C ) and GSPT1 ( B and D ) MBP fusion proteins by recombinant CRL4 CRBN complex. Recombinant protein products as indicated were incubated with or without 80 µM POM ( A and C ) or 80 µM CC-885 ( B and D ) in the ubiquitination assay buffer containing 80 mM ATP at 30°C for 2 hr, and then analyzed by immunoblotting. ( E ) Sequential in vitro ubiquitination of GSPT1 by recombinant CRL4 CRBN complex. MBP-GSPT1 recombination protein was incubated with Ube1, UBE2D3, Cul4-Rbx1, DDB1-cereblon, Ubiquitin, ATP and CC-885 in the ubiquitination assay at 30°C for 4 hr. After purification over size-exclusion chromatography, pre-ubiquitinated MBP-GSPT1 protein was then incubated with Ube1, DDB1-cereblon, Ubiquitin, ATP and UBE2G1 with or without CC-885 or Cul4A-Rbx1 in the ubiquitination assay at 30°C for 2 hr, followed by immunoblot analysis. ( F ) Schematic showing the sequential ubiquitination of CRBN neomorphic substrates by UBE2D3 and UBE2G1. Results shown in ( A–E ) are representative of three independent experiments.
Article Snippet: Antibody , anti-UBE2D3 (rabbit polyclonal antibody) , Sigma-Aldrich , RRID: AB_10605875 , WB (1: 1,000).
Techniques: In Vitro, Recombinant, Incubation, Ubiquitin Assay, Western Blot, Purification, Size-exclusion Chromatography